GF-17

GF-17 is a polypeptide containing 17 amino acids. is the precursor peptide of GF19. GF-17 exhibits significant antiviral activity at concentrations of 35-45 μM in HCECs. GF-17 has good biocompatibility. GF-17 can be used for research on viral infections such as HSV-1 virus[1].

12352209

HSV

Anti-infection

COVID-19-anti-virus

Infection

O=C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](CCCCN)C(N[C@@H](CCCNC(N)=N)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](C(C)C)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCCCN)C(N[C@@H](CC(O)=O)C(N[C@@H](CC2=CC=CC=C2)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(N)=O)C(N[C@@H](CC(C)C)C(N[C@@H](C(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CN

C97H164N30O22

2102.53

[1]Thathapudi NC, et al. Modified host defence peptide GF19 slows TNT-mediated spread of corneal herpes simplex virus serotype I infection. Sci Rep. 2024 Feb 19;14 (1) :4096.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-P11160/

Peptides

No Development Reported